# ANTICOAGULANT SODIUM CITRATE

NDC: 0338-9669
Generic name: trisodium citrate dihydrate
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: EXTRACORPOREAL
Marketing started: 20240402

FDA application: BN980123

## Active ingredients

- TRISODIUM CITRATE DIHYDRATE: 40 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-9669"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-9669
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7025a0f9-1a56-4416-a3a4-925d755aed90